Cheryl Cohen

Insider Reports History

Entity
Individual
Location
C/O Medivation, Inc., 201 Spear St., 3 Rd Floor, San Francisco, CA
Signature
/s/ Sam Martin, attorney-in-fact for Cheryl L. Cohen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cheryl Cohen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aerpio Pharmaceuticals, Inc. Director Common Stock 16.2K $33.3K $2.06 Jun 30, 2021 Direct
MEI Pharma, Inc. Director Stock Option (Right to Buy) 87.5K Jul 5, 2022 Direct
ImmunityBio, Inc. Director Stock Option (right to buy) 77.6K Jun 11, 2024 Direct
Celldex Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 16.5K Jun 13, 2024 Direct

Insider Reports Filed by Cheryl Cohen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLDX Celldex Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
IBRX ImmunityBio, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
CLDX Celldex Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
IBRX ImmunityBio, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
MEIP MEI Pharma, Inc. Jul 5, 2022 1 $0 4 Jul 7, 2022 Director
CLDX Celldex Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
CLDX Celldex Therapeutics, Inc. Jun 16, 2022 0 $0 3 Jun 17, 2022 Director
IBRX ImmunityBio, Inc. Jun 14, 2022 1 $0 4 Jun 15, 2022 Director
IBRX ImmunityBio, Inc. Aug 20, 2021 2 -$250K 4 Aug 24, 2021 Director
IBRX ImmunityBio, Inc. Aug 17, 2021 2 -$461K 4 Aug 19, 2021 Director
MEIP MEI Pharma, Inc. Jul 1, 2021 1 $0 4 Jul 6, 2021 Director
AADI Aerpio Pharmaceuticals, Inc. Jun 30, 2021 1 $12.4K 4 Jul 2, 2021 Director
AADI Aerpio Pharmaceuticals, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director
IBRX ImmunityBio, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director